Pharma Foods cuts FY July 2026 sales forecast, raises operating profit outlook to JPY 2.6 billion

• Pharma Foods cut FY ended July 2026 net sales forecast to JPY 63.2 billion from JPY 67 billion.
• Operating profit outlook raised to JPY 2.6 billion from JPY 2 billion; ordinary profit lifted to JPY 2.4 billion from JPY 2 billion.
• Net income attributable to owners forecast at JPY 1.95 billion, up from JPY 1.5 billion; EPS seen at JPY 67.14 versus JPY 51.65.
• Sales expected to miss on lower revenue, while profit beats reflect tighter cost control and a shift toward profitability and capital efficiency.
• Stronger demand cited for PharmaGABA overseas, steady Newmo Series sales, growth in newer B2C products, and rising interest in ovoveil.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma Foods International Co. Ltd. published the original content used to generate this news brief on September 09, 2026, and is solely responsible for the information contained therein.